M&A Deal Summary |
|
---|---|
Date | 2017-10-17 |
Target | Tekni-Plex |
Sector | Packaging |
Buyer(s) | Genstar Capital |
Sellers(s) | American Capital |
Deal Type | Secondary Buyout |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1988 |
PE ASSETS | 49.0B USD |
Size | Mega |
Type | Sector Agnostic |
Genstar Capital is a private equity firm that seeks investments in life science, healthcare, medical products, industrial technology, software, financial services, packaging, building materials, manufacturing, and business services companies. Genstar looks to invest between $50 and $400 million of equity capital in businesses valued up to $1 billion. Target transaction situations include control-oriented leveraged buyouts of corporate divisions, privately held businesses or public companies, minority investments in privately held businesses or public companies, ownership restructurings/recapitalizations of privately held businesses, growth equity financings, partnerships with other strategic or financial buyers, and take privates. Genstar Capital was formed in 1988 and is based in San Francisco, California.
DEAL STATS | # |
---|---|
Overall | 70 of 109 |
Sector (Packaging) | 3 of 4 |
Type (Secondary Buyout) | 26 of 49 |
State (Pennsylvania) | 4 of 6 |
Country (United States) | 64 of 101 |
Year (2017) | 9 of 10 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-10-03 |
MW Components
Charlotte, North Carolina, United States MW Components is a manufacturer of products that make machines, engines, and complex sub-assemblies work harder, better, longer, and faster. Its full line of industrial springs, fasteners, machined parts, and flat-stamped spring-related products are engineered for peak performance and made from the world's best materials. MW Components is based in Charlotte, North Carolina. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-10-23 |
Bullhorn
Boston, Massachusetts, United States Bullhorn is a provider of SaaS-based front office software for staffing and recruiting firms. Bullhorn’s offerings combine applicant tracking, customer relationship management, social media recruiting, online job posting, candidate sourcing, email and calendar integration, and business development tools. Bullhorn was founded in 1999 and is based in Boston, Massachusetts. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1997 |
PE ASSETS | 22.0B USD |
Size | Mega |
Type | Sector Agnostic |
American Capital was a publicly traded buyout and mezzanine investment firm. American Capital invested in buyouts, growth capital financings, acquistion financings, and recapitalizations. The Firm looked to finance businesses with at least $4 million in EBITDA and valued between $20 and $500 million. American Capital ws a generalist firm with broad interest in traditional industries such as manufacturing, distribution, and services. American Capital's European investment affiliate is European Capital. European Capital looked to invest $10 to $600 million of equity, mezzanine, and/or senior debt in similar opportunities across Europe. American Capital was formed in 1997 and in January 2017, merged with Ares Capital Management.
DEAL STATS | # |
---|---|
Overall | 185 of 194 |
Sector (Packaging) | 4 of 4 |
Type (Secondary Buyout) | 66 of 71 |
State (Pennsylvania) | 10 of 11 |
Country (United States) | 177 of 186 |
Year (2017) | 5 of 8 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-09-11 |
Datapipe
Jersey City, New Jersey, United States Datapipe provides application management, hosting, professional services and security services for mid to large-sized organizations. Datapipe was formed in 1998 and is headquartered in Jersey City, New Jersey. |
Sell | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2017-11-07 |
Schulman Associates IRB
Cincinnati, Ohio, United States Schulman Associates IRB, Inc. is a Independent institutional review board overseeing the review of research protocols and consent documents used to protect human subjects participating in pharmaceutical, biotech, and medical device trials. |
Sell | - |